Literature DB >> 17881291

Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.

Ban Al-Sayyed1, Sajida Piperdi, Xinni Yuan, Anping Li, Gurdyal S Besra, William R Jacobs, Arturo Casadevall, Aharona Glatman-Freedman.   

Abstract

Mycobacterium tuberculosis CDC 1551, a highly immunogenic outbreak strain, previously reported to have unique surface distribution of capsular polysaccharide, was used to generate novel monoclonal antibodies (mabs) to surface mycobacterial targets. Two immunoglobulin G1 (IgG1) mAbs, 16a1 and 16a6 were generated. The mAbs originated from the same B cell, bound strongly to whole cell M. tuberculosis CDC1551 and to its cell wall, membrane and cytosol fractions recognizing a 90kDa protein. Immunoprecipitation using mAb 16a1 isolated a protein with amino acid peptide sequences matching MPT51 from the cytosol. This immunogenic protein of unknown function was previously reported only in culture filtrates of M. tuberculosis. Our findings suggest for the first time that this protein is found within the M. tuberculosis cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881291      PMCID: PMC2475595          DOI: 10.1016/j.tube.2007.07.005

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  34 in total

1.  Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope.

Authors:  M Jackson; C Raynaud; M A Lanéelle; C Guilhot; C Laurent-Winter; D Ensergueix; B Gicquel; M Daffé
Journal:  Mol Microbiol       Date:  1999-03       Impact factor: 3.501

2.  Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.

Authors:  D R Ronning; T Klabunde; G S Besra; V D Vissa; J T Belisle; J C Sacchettini
Journal:  Nat Struct Biol       Date:  2000-02

3.  The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

Authors:  K Pethe; S Alonso; F Biet; G Delogu; M J Brennan; C Locht; F D Menozzi
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

4.  Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis.

Authors:  Krishna K Singh; Yuxin Dong; John T Belisle; Jeffrey Harder; Vijay K Arora; Suman Laal
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

5.  A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival.

Authors:  R Teitelbaum; A Glatman-Freedman; B Chen; J B Robbins; E Unanue; A Casadevall; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.

Authors:  C Manca; L Tsenova; C E Barry; A Bergtold; S Freeman; P A Haslett; J M Musser; V H Freedman; G Kaplan
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

7.  Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M.

Authors:  A Glatman-Freedman; A J Mednick; N Lendvai; A Casadevall
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

8.  Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.

Authors:  Vasan K Sambandamurthy; Steven C Derrick; Tsungda Hsu; Bing Chen; Michelle H Larsen; Kripa V Jalapathy; Mei Chen; John Kim; Steven A Porcelli; John Chan; Sheldon L Morris; William R Jacobs
Journal:  Vaccine       Date:  2006-06-12       Impact factor: 3.641

9.  Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection.

Authors:  I Rosenkrands; K Weldingh; S Jacobsen; C V Hansen; W Florio; I Gianetri; P Andersen
Journal:  Electrophoresis       Date:  2000-03       Impact factor: 3.535

10.  Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan.

Authors:  Aharona Glatman-Freedman; Arturo Casadevall; Zongdong Dai; William R Jacobs; Anping Li; Sheldon L Morris; Josepine Anne D Navoa; Sajida Piperdi; John B Robbins; Rachel Schneerson; J Reid Schwebach; Michael Shapiro
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 11.677

View more
  4 in total

1.  Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors.

Authors:  Hui-Chen Chang Foreman; Andrew Frank; Timothy T Stedman
Journal:  PLoS One       Date:  2021-08-20       Impact factor: 3.240

2.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

Review 3.  Antibodies and tuberculosis.

Authors:  Ashley J Jacobs; Juthathip Mongkolsapaya; Gavin R Screaton; Helen McShane; Robert J Wilkinson
Journal:  Tuberculosis (Edinb)       Date:  2016-08-26       Impact factor: 3.131

Review 4.  Dormancy models for Mycobacterium tuberculosis: A minireview.

Authors:  Amani M Alnimr
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.